• Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
eXoZymes
Home

Technology

The platform Artificial Intelligence BioClick Scientific papers

Pipeline

Pipeline overview NCT: Over-the-Counter NCT: Pharma Cannabinoids Santalene

Investors

Stock information SEC Filings Email signup

About

About eXoZymes Jobs News
  1. Home

Nasdaq: EXOZ · Video library

Watch the biomanufacturing revolution

Interviews, investor updates and the science behind cell-free production — where chemistry hits its limits and enzymes take over.

Browse the library Investor webinars
Next investor call Register

Latest videos

EXOZ investor update: 2Q 2026 @ August 20, 2026
Webinars
EXOZ investor update: 2Q 2026 @ August 20, 2026 September 22, 2026 · 101 views
Webull 'Biotech Sector' webinar by Perriman
interview
Webull 'Biotech Sector' webinar by Perriman June 30, 2026 · 93 views
Podcast: Water Tower Research spotlights EXOZ CEO Heltzen
interview
Podcast: Water Tower Research spotlights EXOZ CEO Heltzen June 29, 2026 · 83 views
Investor Presentation by Chris Marlett (May 2026)
investors
Investor Presentation by Chris Marlett (May 2026) May 11, 2026 · 703 views
eXoZymes Investor Presentation (April 2026)
investors
eXoZymes Investor Presentation (April 2026) April 18, 2026 · 254 views
Grow Everything: NCT as a Superhero?
interview
Grow Everything: NCT as a Superhero? April 13, 2026 · 58 views
Grow Everything: Nature's Secret Unlocked
interview
Grow Everything: Nature's Secret Unlocked April 13, 2026 · 4,832 views
NCT presentation by Damien Perriman, CCO
investors
NCT presentation by Damien Perriman, CCO April 03, 2026 · 512 views
Nasdaq: Damien Perriman interview on NCT
investors
Nasdaq: Damien Perriman interview on NCT April 02, 2026 · 157 views
EXOZ Investor Update - Q4+2025 (March 31. 2026)
investors
EXOZ Investor Update - Q4+2025 (March 31. 2026) April 01, 2026 · 1,471 views
Nasdaq: Michael B. Spector interviews CEO Heltzen
Heltzen's updates
Nasdaq: Michael B. Spector interviews CEO Heltzen March 18, 2026 · 174 views
Interview: Cayman Chemical validates eXoZymes' technology and scalability
investors
Interview: Cayman Chemical validates eXoZymes' technology and scalability March 18, 2026 · 390 views

eXoZymes Inc.

750 Royal Oaks Dr, st 106, 
Monrovia 91016, CA, USA

P: (626) 415-1488
E: info@exozymes.com

 

© eXoZymes Inc. [Nasdaq:EXOZ] unshackling enzymes since 2019 (formerly known as Invizyne Technologies)

Videos Webinars Investors SEC Filings Privacy Policy Terms of Use